Factors Influencing Intraocular Pressure Elevation During Hemodialysis.
Lee Kyunghee, Park Seungchan, Tantisattamo Ekamol, Ryu Soorack, Yu Sung, Lim Hyejin, Huang Alex S, Lim Su-Ho
AI Summary
This study found intraocular pressure (IOP) transiently rises during hemodialysis, especially with higher pre-dialysis osmolality and in phakic eyes. This highlights the need for ophthalmic monitoring in high-risk dialysis patients.
Abstract
Purpose
The purpose of this study was to investigate intraocular pressure (IOP) and mean ocular perfusion pressure (MOPP) fluctuations during hemodialysis (HD) and identify clinical and HD-related factors associated with IOP elevation.
Methods
This prospective, observational, single-center study included 103 eyes of 56 patients undergoing maintenance HD. IOP was measured at 5 time points: pre-dialysis (T0), 1 hour (T1), 2 hours (T2), 4 hours (T4), and 30 minutes post-dialysis (TP). MOPP was calculated at T0 to T4. Baseline laboratory data, including serum osmolality (PreOsm), were collected. Generalized estimating equation models evaluated the effects of time, lens status, and osmolality on IOP. Receiver operating characteristic (ROC) analysis was used to identify a PreOsm threshold for predicting IOP elevation >5 millimeters of mercury (mm Hg).
Results
IOP increased during HD, peaking at 4 hours (17.5 ± 0.5 mm Hg) and returning to baseline at TP (14.6 ± 0.4 mm Hg, P < 0.001). MOPP declined over time. Phakic eyes showed significantly greater IOP at 1 and 2 hours compared with pseudophakic eyes (P = 0.022 and 0.048, respectively). Patients with PreOsm >312 milliosmolar (mOsm)/kg had greater IOP increases and were more likely to exhibit IOPrise >5 mm Hg in univariate and multivariate analyses (odds ratio [OR] = 3.94, 95% confidence interval [CI] = 1.21-12.79, P = 0.022 and OR = 3.38, 95% CI = 1.01-11.3, P = 0.048, respectively). Phakic lens status was associated with IOP elevation in univariate analysis (OR = 2.38, 95% CI = 1.01-5.56, P = 0.049), but in multivariate analysis, there was only a trend (P = 0.072).
Conclusions
Transient intra-dialytic IOP elevation may be influenced by osmolality more so than lens status.
Translational relevance: These findings support the concept of ocular disequilibrium during HD and highlight the need for targeted ophthalmic monitoring in high-risk patients.
MeSH Terms
Key Concepts5
Intraocular pressure (IOP) increased during hemodialysis (HD) in 103 eyes of 56 patients, peaking at 4 hours (17.5 ± 0.5 mm Hg) and returning to baseline at 30 minutes post-dialysis (14.6 ± 0.4 mm Hg, P < 0.001).
Patients undergoing hemodialysis (HD) with pre-dialysis serum osmolality (PreOsm) >312 milliosmolar (mOsm)/kg had greater intraocular pressure (IOP) increases and were more likely to exhibit IOP elevation >5 mm Hg (odds ratio [OR] = 3.94, 95% confidence interval [CI] = 1.21-12.79, P = 0.022 in univariate analysis; OR = 3.38, 95% CI = 1.01-11.3, P = 0.048 in multivariate analysis) in 103 eyes of 56 patients.
Transient intra-dialytic intraocular pressure (IOP) elevation during hemodialysis (HD) may be influenced by osmolality more so than lens status.
Phakic eyes showed significantly greater intraocular pressure (IOP) at 1 hour (P = 0.022) and 2 hours (P = 0.048) during hemodialysis (HD) compared with pseudophakic eyes, among 103 eyes of 56 patients.
This prospective, observational, single-center study included 103 eyes of 56 patients undergoing maintenance hemodialysis (HD) to investigate intraocular pressure (IOP) and mean ocular perfusion pressure (MOPP) fluctuations.
Related Articles5
Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study.
Observational StudyOutcomes of gonioscopy-assisted transluminal trabeculotomy in advanced pigmentary glaucoma.
Randomized Controlled TrialNeovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation.
Cohort StudyGlaucoma in Older Asians Aged 60 to 100 Years: Prevalence, Factors, Trends, and Projections (2024-2040).
Cohort StudyThe PAUL Glaucoma Implant in the management of uveitic glaucoma-3-year follow-up.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.